Quick Answer
Tonix Pharmaceuticals Holding Corp. reported Long Term Debt Noncurrent of $4.67 million for the year ending 2024.
- Tonix Pharmaceuticals Holding Corp. showed a decrease of -28.9% in Long Term Debt Noncurrent from 2023 to 2024.
- This data is from Tonix Pharmaceuticals Holding Corp.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2023 to 2024 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2024: $6.16 million | Q2 2024: $5.67 million | Q3 2024: $5.17 million.
- Historical annual values: Fiscal year 2024: $4.67 million | Fiscal year 2023: $6.56 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: